View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

NSF International to Attend 2nd PDA Europe Annual Meeting, Germany

NSF International’s pharma biotech team has announced it will be present at the 2nd PDA Europe Annual Meeting in Berlin.

Global vice-president of NSF Pharma Biotech and Medical Devices Martin Lush will open this prestigious event with keynote presentation, ‘The Political Landscape and the Future of the Pharmaceutical Industry’. In preparation for this session, Martin has asked for the views and opinions of more than 1,000 industry experts from across the world. So, if you’re interested in your future, don’t miss this session or find Martin at the NSF booth (13). He will be available to give you his insight and answers.

Taking place from 13 June to 14 June, the event’s main theme is global healthcare of the present and the future, building a bridge between current demands in the global healthcare industry, big data issues, and promising personalised medicine and medicinal products.

The meeting will also include presentations from regulatory, industry, and technology representatives from around the world.

NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology